Toward an evidence-based toxicology

被引:103
作者
Hoffmann, S. [1 ]
Hartung, T. [1 ]
机构
[1] European Commiss, JRC, Inst Hlth & Consumer Protect, ECVAM, I-21020 Ispra, VA, Italy
关键词
evidence-based; reliability; test assessment; toxicology; validation; relevance;
D O I
10.1191/0960327106het648oa
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The increasing demands on toxicology of large-scale risk assessment programmes for chemicals and emerging or expanding areas of chemical use suggest it is timely to review the toxicological toolbox. Like in clinical medicine, where an evidence-based medicine (EBM) is critically reviewing traditional approaches, toxicology has the opportunity to reshape and enlarge its methodology and approaches on the basis of compounded scientific knowledge. Such revision would have to be based on structured reviews of current practice, ie, assessment of test performance characteristics, mechanistic understanding, extended quality assurance, formal validation and the use of integrated testing strategies. This form of revision could optimize the balance between safety, costs and animal welfare, explicitly stating and, where possible, quantifying uncertainties. After a self-critical reassessment of current practices and evaluation of the thus generated information, such an evidence-based toxicology (EBT) promises to make better use of resources and to increase the quality of results, facilitating their interpretation. It shall open up hazard and also risk assessments to new technologies, flexibly accommodating current and future mechanistic understanding. An EBT will be better prepared to answer the continuously growing safety demands of modern societies.
引用
收藏
页码:497 / 513
页数:17
相关论文
共 157 条
[41]   Meta-analysis: Principles and procedures [J].
Egger, M ;
Smith, GD ;
Phillips, AN .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7121) :1533-1537
[42]   Meta-analysis - Potentials and promise [J].
Egger, M ;
Smith, GD .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7119) :1371-1374
[43]   Methods of in vitro toxicology [J].
Eisenbrand, G ;
Pool-Zobel, B ;
Baker, V ;
Balls, M ;
Blaauboer, BJ ;
Boobis, A ;
Carere, A ;
Kevekordes, S ;
Lhuguenot, JC ;
Pieters, R ;
Kleiner, J .
FOOD AND CHEMICAL TOXICOLOGY, 2002, 40 (2-3) :193-236
[44]  
Ekwall E, 1998, ATLA-ALTERN LAB ANIM, V26, P571
[45]   THE PREDICTIVITY OF ANIMAL BIOASSAYS AND SHORT-TERM GENOTOXICITY TESTS FOR CARCINOGENICITY AND NON-CARCINOGENICITY TO HUMANS [J].
ENNEVER, FK ;
NOONAN, TJ ;
ROSENKRANZ, HS .
MUTAGENESIS, 1987, 2 (02) :73-78
[46]   Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity [J].
Ennever, FK ;
Lave, LB .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2003, 38 (01) :52-57
[47]   Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown [J].
Enoe, C ;
Georgiadis, MP ;
Johnson, WO .
PREVENTIVE VETERINARY MEDICINE, 2000, 45 (1-2) :61-81
[48]   Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs [J].
Eriksson, L ;
Jaworska, J ;
Worth, AP ;
Cronin, MTD ;
McDowell, RM ;
Gramatica, P .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2003, 111 (10) :1361-1375
[49]   Laboratory animal science issues in the design and conduct of studies with endocrine-active compounds [J].
Everitt, JI ;
Foster, PMD .
ILAR JOURNAL, 2004, 45 (04) :417-424
[50]  
FARLAND WH, 2005, BMJ-BRIT MED J, V331, pE390